AffiELISA® Canine DR-70TM ELISA Kit
The AffiELISA® Canine DR-70TM ELISA Kit is a specialized laboratory tool designed for the quantitative measurement of the tumor marker DR-70TM in canine (dog) samples.
DR-70TM is a biomarker used in veterinary medicine for cancer detection, particularly in dogs. It's associated with certain types of cancers, including lung cancer, and can be elevated in the blood of dogs affected by these conditions.
ELISA (Enzyme-Linked Immunosorbent Assay) is a widely used laboratory technique that utilizes specific antibodies to detect and quantify particular molecules or proteins in biological samples. This kit employs antibodies specifically designed to recognize canine DR-70TM, enabling the precise measurement and quantification of its concentration in canine samples.
Measuring DR-70TM levels in dogs using ELISA kits like the AffiELISA® Canine DR-70TM Kit assists veterinarians in diagnosing and monitoring cancer in dogs. Elevated levels of DR-70TM can indicate the presence of certain types of cancer, aiding in the early detection, monitoring of disease progression, and response to treatment.
This specialized ELISA kit provides a valuable tool for veterinary oncologists and clinicians in assessing and managing cancer in dogs, allowing for more accurate diagnosis and treatment monitoring, ultimately contributing to improved outcomes for canine patients affected by cancer.
Product Specifications
Species
Canine
Gene / Target
N/A
Assay Type
Sandwich ELISA
Assay Length
3-4 hours
Canine DR-70TM Background
Canine DR-70TM is a tumor marker used in veterinary medicine, particularly in the detection and monitoring of certain cancers in dogs. It stands for "Dog-Race 70 tumor marker."
DR-70TM is associated with specific types of cancers in dogs, notably lung cancer, though its use and effectiveness in detecting various other types of cancers in canines are also being explored.
Veterinary professionals utilize DR-70TM testing as a part of their diagnostic approach for identifying and monitoring cancer in dogs. Elevated levels of DR-70TM in blood or other bodily fluids may indicate the presence of certain cancers, aiding in the early detection and management of the disease in dogs.
Tests such as ELISA (Enzyme-Linked Immunosorbent Assay) kits developed for detecting canine DR-70TM allow for the quantification of this tumor marker in dog samples. Monitoring DR-70TM levels can assist veterinarians in evaluating the progression of cancer, assessing the response to treatment, and potentially predicting outcomes in canine cancer patients.
While DR-70TM testing can be a valuable tool in veterinary oncology, it's important to note that tumor markers like DR-70TM are not definitive diagnostic tools on their own. They are used in conjunction with other clinical assessments, imaging techniques, and tests to aid in the diagnosis and management of cancer in dogs.